Ignite Creation Date:
2025-12-24 @ 1:59 PM
Ignite Modification Date:
2026-01-29 @ 1:10 PM
Study NCT ID:
NCT04344795
Status:
COMPLETED
Last Update Posted:
2025-09-12
First Post:
2020-04-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase 1a/1b Study of TPST-1495 as a Single Agent and in Combination With Pembrolizumab in Subjects With Solid Tumors
Sponsor:
Tempest Therapeutics
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Solid Tumor | View |
| None | Colorectal Cancer | View |
| None | Non Small Cell Lung Cancer | View |
| None | Squamous Cell Carcinoma of Head and Neck | View |
| None | Urothelial Carcinoma | View |
| None | Endometrial Cancer | View |
| None | Gastroesophageal Junction Adenocarcinoma | View |
| None | Gastric Adenocarcinoma | View |
| None | Solid Tumors With PIK3Ca Mutation | View |